The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)

项目摘要 大西洋健康癌症联盟社区肿瘤学研究计划（AHCC-CORP）是第一个 NCORP社区网站内的新泽西州，并结合了集体的力量，世界一流的 医疗保健系统与社区肿瘤护理服务。AHCC-CORP涵盖地理和 代表新泽西73%人口的人口多样化地区。AHCC-CORP扩展了 NCORP网络覆盖650万人;癌症发病率高于美国整体（477.5 vs 441.2 每100，000例）。AHCC-CORP的区域甚至进一步升高。 具体目标包括：1）增加成人和儿童对NCI癌症预防，控制， 筛查和护理提供研究，以及治疗和成像研究， 国家临床试验网络（NCTN）和生物标本采集。 这将通过 在新泽西创建了一个独特的、前所未有的癌症护理联盟。 财团经历了 癌症研究人员在成人和儿童癌症在多个网站，包括三个儿童医院。 另外，联盟的研究中心每年平均有130名参与者加入NCORP研究基地， 在AHCC-CORP的领导和基础设施支持下，子公司现在准备进一步 增加应计利润。 2)加强社区参与癌症控制和预防临床试验 以及NCORP在AHCC-CORP集水区开展的癌症护理提供研究（CCDR）。 将通过创新方法加强参与，有效地让医生、患者和 社会各界发展情况主要包括用于社交媒体传播和互动的视频短片 由自然语言处理提供支持的聊天机器人功能， 多种语言支持癌症差异整合。此外，AHCC-CORP有一个明确的 NCORP和NCTN试验激活的优先顺序流程，以及支持成功研究的程序 AHCC-CORP还将支持和指导社区肿瘤学家， 其他医疗专家在中部和北方新泽西，进一步提高能力，在癌症护理提供 research. 3)促进具有临床意义的研究的开发和实施， 将不同人群的独特研究需求纳入AHCC NCORP流域 利用现有肿瘤专科医生和其他提供者的专业知识， 我们的联盟网络。 已建立的临床和研究专业知识，跨多种肿瘤类型， 将利用AHCC-CORP医生和其他提供者的研究模式来支持NCORP 通过积极参与研究基地和其他NCORP-wide 研究领导委员会。

Project Summary Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC-CORP) is the first NCORP Community Site within the state of New Jersey and combines the collective strengths of world-class healthcare systems with community oncology care delivery. AHCC-CORP covers a geographically and demographically diverse area representing 73% of New Jersey’s population. AHCC-CORP expands the NCORP network by 6.5M people; with a higher cancer incidence rate than the US as a whole (477.5 vs 441.2 cases per 100,000). Regions of AHCC-CORP are even further elevated. Specific Aims include: ​1) Increase adult and pediatric accruals to NCI cancer prevention, control, screening, and care delivery research studies, as well as treatment and imaging studies conducted by the National Clinical Trials Network (NCTN) and biospecimen collection​. ​This will be accomplished by creating a unique and unprecedented cancer care consortium in New Jersey​. ​The Consortium has experienced cancer investigators in adult and pediatric cancers across multiple sites, including three children's hospitals. Separately, Consortium sites annually accrue an average of 130 ​participants to NCORP Research Bases, but with the leadership and infrastructure support of AHCC-CORP, affiliates are now poised to even further increase accruals. ​2) Enhance community engagement in ​cancer control and prevention clinical trials and Cancer Care Delivery Research (CCDR) conducted by NCORP ​in the AHCC-CORP ​catchment area. Engagement will be enhanced through innovative approaches that effectively engage physicians, patients, and the community. Developments ​notably include video vignettes for social media dissemination and interactive chatbot capabilities powered by natural language processing, allowing recruitment/retention strategies in multiple languages in support of cancer disparities integration. Additionally, AHCC-CORP ​has a clearly-defined process for prioritizing NCORP and NCTN trials for activation, and procedures in support of successful study accrual and data collection across sites.​ AHCC-CORP will also support and mentor community oncologists and other medical specialists in central and northern New Jersey​, furthering capabilities in cancer care delivery research. ​3) Contribute to the development and implementation of clinically significant studies that incorporate the unique research needs of the diverse population within the AHCC NCORP catchment area, leveraging the expertise of established oncology specialty physicians and other providers within our affiliate network. ​The established clinical and research expertise, across multiple tumor types and research modalities, of AHCC-CORP physicians and other providers will be leveraged to support NCORP overarching programmatic goals through ​active involvement in Research Bases and other NCORP-wide research leadership committees.